Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 10, 2017 · 10-Q · 40 days after period end · 0001171843-17-002898
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$6.50M | -$6.55M | -$4.58M | -$2.83M |
| EPS Diluted | -$0.39 | -$0.40 | -$0.28 | -$18.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 10, 2017 · 40 d after period end
